Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Oncology Institute (TOI) Other Non-Current Liabilities: 2020-2024

Historic Other Non-Current Liabilities for Oncology Institute (TOI) over the last 5 years, with FY2024 value amounting to $385000.0.

  • Oncology Institute's Other Non-Current Liabilities rose 255719.84% to $13.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.7 million, marking a year-over-year increase of 255719.84%. This contributed to the annual value of $385000.0 for FY2024, which is 8750.81% down from last year.
  • Per Oncology Institute's latest filing, its Other Non-Current Liabilities stood at $385000.0 for FY2024, which was down 8750.81% from $3.1 million recorded in FY2023.
  • Oncology Institute's Other Non-Current Liabilities' 5-year high stood at $6.9 million during FY2021, with a 5-year trough of $385000.0 in FY2024.
  • For the 5-year period, Oncology Institute's Other Non-Current Liabilities averaged around $3.0 million, with its median value being $3.1 million (2023).
  • Its Other Non-Current Liabilities has fluctuated over the past 5 years, first soared by 75501.86% in 2021, then crashed by 8750.81% in 2024.
  • Oncology Institute's Other Non-Current Liabilities (Annual) stood at $807000.0 in 2020, then skyrocketed by 755.02% to $6.9 million in 2021, then tumbled by 42.61% to $4.0 million in 2022, then fell by 22.17% to $3.1 million in 2023, then plummeted by 87.51% to $385000.0 in 2024.
  • Its last three reported values are $385000.0 in FY2024, $3.1 million for FY2023, and $4.0 million during FY2022.